Evidence map›Paper›PMID 40551713›Full record

ArticleInterventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2025

M2 vessel occlusion characteristics and outcome after endovascular therapy: A post-hoc pooled analysis of MR CLEAN MED, NO-IV and LATE.

Sterre Dassen, Quirien Robbe, Bart Wagemans, Robrecht Knapen, Susan Olthuis, Linda Jacobi, Christiaan van der Leij, Urs Fischer, Elyas Ghariq, Nyika Kruyt and 7 more

Abstract read
In one paragraph

Article in Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sterre DassenSchool for Cardiovascular Diseases (CARIM), Maastricht University Medical Center+, Maastricht, the Netherlands.ORCID 0009-0004-3182-7286
Quirien RobbeSchool for Cardiovascular Diseases (CARIM), Maastricht University Medical Center+, Maastricht, the Netherlands.
Bart WagemansDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.ORCID 0000-0003-4898-1592
Robrecht KnapenSchool for Cardiovascular Diseases (CARIM), Maastricht University Medical Center+, Maastricht, the Netherlands.ORCID 0000-0003-4677-3685
Susan OlthuisSchool for Cardiovascular Diseases (CARIM), Maastricht University Medical Center+, Maastricht, the Netherlands.ORCID 0000-0002-2802-1511
Linda JacobiDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
Christiaan van der LeijDepartment of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
Urs FischerDepartment of Neurology, University Hospital Bern, University of Bern, Bern, Switzerland.
Elyas GhariqDepartment of Radiology, Haaglanden Medical Center, The Hague, the Netherlands.
Nyika KruytUniversity Neurovascular Centre (UNVC) Leiden-The Hague, Leiden, the Netherlands.
Wouter van der SteenDepartment of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Natalie LeCouffeDepartment of Neurology, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
Aad van der LugtDepartment of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0002-6159-2228
Charles MajoieDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Amsterdam, the Netherlands.
Wim van ZwamSchool for Cardiovascular Diseases (CARIM), Maastricht University Medical Center+, Maastricht, the Netherlands.ORCID 0000-0003-1631-7056
Adriaan van EsUniversity Neurovascular Centre (UNVC) Leiden-The Hague, Leiden, the Netherlands.
Julie StaalsSchool for Cardiovascular Diseases (CARIM), Maastricht University Medical Center+, Maastricht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PurposeEndovascular treatment (EVT) of M2-segment occlusions in acute ischemic stroke patients is still under debate. The impact of different M2 vessel occlusion characteristics on the outcomes of EVT remains unclear. We evaluated the association between M2 occlusion characteristics and clinical and safety outcomes following EVT.MethodsThis is a retrospective pooled post-hoc analysis of data from the MR CLEAN MED, MR CLEAN NO-IV and MR CLEAN LATE trials, including patients who underwent EVT for M2 occlusions. We classified M2 occlusions on CTA images by location (proximal/distal), vessel dominance, affected branch (superior/inferior) and hemisphere. The primary outcome was the 24-hour National Institutes of Health Stroke Scale (NIHSS) score. Secondary outcomes included ΔNIHSS, a 90-day modified Rankin Scale (mRS) score, EVT procedural characteristics and safety outcomes. We adjusted for relevant prognostic factors.Results181 patients with endovascular-treated M2 occlusions were included. There were no significant differences in 24-hour NIHSS or ΔNIHSS between proximal and distal occlusions. Ordinal shift analysis of mRS showed similar outcomes for proximal and distal M2 occlusions (cOR 1.32, 95% CI 0.70-2.49). Vessel dominance, affected branch and hemisphere did not significantly influence the NIHSS, ΔNIHSS or 90-day mRS. More symptomatic intracranial haemorrhages were seen in EVT of inferior branch occlusion (9.1% versus 2.1%,

Indexed as

middle cerebral arteryStrokethrombectomy

Identifiers

PMID40551713
PMCPMC12187717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.